NIH supports development, testing, and clinical feasibility studies of therapeutic and diagnostic devices for nervous or neuromuscular disorders through milestone-driven cooperative agreements.
This grant has transitioned from forecasted to posted and is now accepting applications.
Encourages translational activities and small clinical studies for neural devices to address disorders affecting the nervous system; includes prototype development, safety testing, and clinical validation.
NIH supports development of next-generation diagnostic and therapeutic devices aligned with its brain research and addiction initiatives, preparing them for first-in-human trials; clinical trials are not allowed.
NHLBI Catalyze program supports early-stage medical device prototype optimization and translational research for heart, lung, blood, and sleep (HLBS) diseases.
This grant supports interdisciplinary team research to understand and optimize how therapeutic medical devices work, aiming to improve patient outcomes for neurological and related conditions.
NIH supports small, multidisciplinary teams using bioengineering to solve biomedical problems and advance tools, with optional trials to test functionality or performance, excluding phase III trials.